Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Neutral diagnosis: An innovative concept for medical device clinical trials.

Zhang B, Ye S, Shankara SB, Zhang H, Zheng Q.

Contemp Clin Trials Commun. 2019 Aug 21;16:100436. doi: 10.1016/j.conctc.2019.100436. eCollection 2019 Dec.

2.

Differences in patient characteristics and care practices between two trials of therapeutic hypothermia.

Bonifacio SL, McDonald SA, Chock VY, Wusthoff CJ, Hintz SR, Laptook AR, Shankara S, Van Meurs KP.

Pediatr Res. 2019 Jun;85(7):1008-1015. doi: 10.1038/s41390-019-0371-2. Epub 2019 Mar 12.

PMID:
30862961
3.

Impact of alemtuzumab treatment on the survival and function of human regulatory T cells in vitro.

Havari E, Turner MJ, Campos-Rivera J, Shankara S, Nguyen TH, Roberts B, Siders W, Kaplan JM.

Immunology. 2014 Jan;141(1):123-31. doi: 10.1111/imm.12178.

4.

Human peripheral blood mononuclear cells exhibit heterogeneous CD52 expression levels and show differential sensitivity to alemtuzumab mediated cytolysis.

Rao SP, Sancho J, Campos-Rivera J, Boutin PM, Severy PB, Weeden T, Shankara S, Roberts BL, Kaplan JM.

PLoS One. 2012;7(6):e39416. doi: 10.1371/journal.pone.0039416. Epub 2012 Jun 25.

5.

Expression of TMPRSS4 in non-small cell lung cancer and its modulation by hypoxia.

Nguyen TH, Weber W, Havari E, Connors T, Bagley RG, McLaren R, Nambiar PR, Madden SL, Teicher BA, Roberts B, Kaplan J, Shankara S.

Int J Oncol. 2012 Sep;41(3):829-38. doi: 10.3892/ijo.2012.1513. Epub 2012 Jun 12.

6.

Alemtuzumab induction of intracellular signaling and apoptosis in malignant B lymphocytes.

Nguyen TH, Havari E, McLaren R, Zhang M, Jiang Y, Madden SL, Roberts B, Kaplan J, Shankara S.

Leuk Lymphoma. 2012 Apr;53(4):699-709. doi: 10.3109/10428194.2011.623253. Epub 2011 Nov 25.

PMID:
21916527
7.

Involvement of neutrophils and natural killer cells in the anti-tumor activity of alemtuzumab in xenograft tumor models.

Siders WM, Shields J, Garron C, Hu Y, Boutin P, Shankara S, Weber W, Roberts B, Kaplan JM.

Leuk Lymphoma. 2010 Jul;51(7):1293-304. doi: 10.3109/10428191003777963.

PMID:
20377308
8.

Determination of sex from tooth pulp tissue.

Veeraraghavan G, Lingappa A, Shankara SP, Mamatha GP, Sebastian BT, Mujib A.

Libyan J Med. 2010 Apr 1;5. doi: 10.3402/ljm.v5i0.5084.

9.

Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization.

Bagley RG, Honma N, Weber W, Boutin P, Rouleau C, Shankara S, Kataoka S, Ishida I, Roberts BL, Teicher BA.

Microvasc Res. 2008 Nov;76(3):180-8. doi: 10.1016/j.mvr.2008.07.008. Epub 2008 Aug 8.

PMID:
18761022
10.

Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248.

Bagley RG, Rouleau C, St Martin T, Boutin P, Weber W, Ruzek M, Honma N, Nacht M, Shankara S, Kataoka S, Ishida I, Roberts BL, Teicher BA.

Mol Cancer Ther. 2008 Aug;7(8):2536-46. doi: 10.1158/1535-7163.MCT-08-0050.

11.

The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contribution.

Rouleau C, Menon K, Boutin P, Guyre C, Yoshida H, Kataoka S, Perricone M, Shankara S, Frankel AE, Duesbery NS, Vande Woude G, Biemann HP, Teicher BA.

Int J Oncol. 2008 Apr;32(4):739-48.

PMID:
18360701
12.

Characterization of in vitro antimurine thymocyte globulin-induced regulatory T cells that inhibit graft-versus-host disease in vivo.

Ruzek MC, Waire JS, Hopkins D, Lacorcia G, Sullivan J, Roberts BL, Richards SM, Nahill SR, Williams JM, Scaria A, Dzuris J, Shankara S, Garman RD.

Blood. 2008 Feb 1;111(3):1726-34. Epub 2007 Nov 19.

PMID:
18025149
13.

Development of a simple and rapid method for producing non-fucosylated oligomannose containing antibodies with increased effector function.

Zhou Q, Shankara S, Roy A, Qiu H, Estes S, McVie-Wylie A, Culm-Merdek K, Park A, Pan C, Edmunds T.

Biotechnol Bioeng. 2008 Feb 15;99(3):652-65.

PMID:
17680659
14.

Pericytes from human non-small cell lung carcinomas: an attractive target for anti-angiogenic therapy.

Bagley RG, Rouleau C, Morgenbesser SD, Weber W, Cook BP, Shankara S, Madden SL, Teicher BA.

Microvasc Res. 2006 May;71(3):163-74. Epub 2006 Apr 19.

PMID:
16624341
15.

Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function.

Rouleau C, Roy A, St Martin T, Dufault MR, Boutin P, Liu D, Zhang M, Puorro-Radzwill K, Rulli L, Reczek D, Bagley R, Byrne A, Weber W, Roberts B, Klinger K, Brondyk W, Nacht M, Madden S, Burrier R, Shankara S, Teicher BA.

Mol Cancer Ther. 2006 Feb;5(2):219-29.

16.

Identification of a binding partner for the endothelial cell surface proteins TEM7 and TEM7R.

Nanda A, Buckhaults P, Seaman S, Agrawal N, Boutin P, Shankara S, Nacht M, Teicher B, Stampfl J, Singh S, Vogelstein B, Kinzler KW, St Croix B.

Cancer Res. 2004 Dec 1;64(23):8507-11.

17.

Quantitative real-time RT-PCR as a method for monitoring T lymphocyte reactivity to full-length tyrosinase protein in vaccinated melanoma patients.

Housseau F, Lindsey KR, Oberholtzer SD, Gonzales MI, Boutin P, Moorthy AK, Shankara S, Roberts BL, Topalian SL.

J Immunol Methods. 2002 Aug 1;266(1-2):87-103.

PMID:
12133625
18.

Gene expression profiles in human cardiac cells subjected to hypoxia or expressing a hybrid form of HIF-1 alpha.

Jiang C, Lu H, Vincent KA, Shankara S, Belanger AJ, Cheng SH, Akita GY, Kelly RA, Goldberg MA, Gregory RJ.

Physiol Genomics. 2002 Feb 11;8(1):23-32.

PMID:
11842128
19.

Mechanisms of cell death induced by suicide genes encoding purine nucleoside phosphorylase and thymidine kinase in human hepatocellular carcinoma cells in vitro.

Krohne TU, Shankara S, Geissler M, Roberts BL, Wands JR, Blum HE, Mohr L.

Hepatology. 2001 Sep;34(3):511-8.

PMID:
11526536
20.

Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele.

Gnjatic S, Nagata Y, Jager E, Stockert E, Shankara S, Roberts BL, Mazzara GP, Lee SY, Dunbar PR, Dupont B, Cerundolo V, Ritter G, Chen YT, Knuth A, Old LJ.

Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10917-22.

21.

Immunogene therapy for murine melanoma using recombinant adenoviral vectors expressing melanoma-associated antigens.

Perricone MA, Claussen KA, Smith KA, Kaplan JM, Piraino S, Shankara S, Roberts BL.

Mol Ther. 2000 Mar;1(3):275-84.

22.

In vitro priming with adenovirus/gp100 antigen-transduced dendritic cells reveals the epitope specificity of HLA-A*0201-restricted CD8+ T cells in patients with melanoma.

Linette GP, Shankara S, Longerich S, Yang S, Doll R, Nicolette C, Preffer FI, Roberts BL, Haluska FG.

J Immunol. 2000 Mar 15;164(6):3402-12.

23.

Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene.

Mohr L, Shankara S, Yoon SK, Krohne TU, Geissler M, Roberts B, Blum HE, Wands JR.

Hepatology. 2000 Mar;31(3):606-14.

PMID:
10706550
24.

Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens.

Kaplan JM, Yu Q, Piraino ST, Pennington SE, Shankara S, Woodworth LA, Roberts BL.

J Immunol. 1999 Jul 15;163(2):699-707.

Supplemental Content

Loading ...
Support Center